<DOC>
	<DOCNO>NCT02732548</DOCNO>
	<brief_summary>This study conduct collect data performance Miromatrix Wound Matrix ( MIRODERM ) use treatment complex wound inpatient setting .</brief_summary>
	<brief_title>MIRODERM™ Complex Wounds Inpatient Setting ( MIRODERM CLOSure )</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>Be least 18 year old Have complex study wound require autograft delay primary closure procedure may may include tunnel and/or undermine Have study wind total postdebridement surface area ≥50cm2 ≤250cm2 dimension &gt; 25cm , minimum depth ≥0.5cm Have study wound expect take least 4 week reach autograft delay primary closure use standard care NPWT Have study wound treat NPWT regardless study participation Be inpatient set Be able willing sign consent form comply study visit procedure Be pregnant plan become pregnant study Be contraindicate NPWT ( necrotic tissue eschar present , untreated osteomyelitis , nonenteric unexplored fistula , malignancy wound , expose vasculature , exposed nerve , expose anastomotic site , exposed organ ) Be immunocompromised risk immunosuppression ( e.g . HIV positive , experience organ rejection , recent , current , anticipated chemotherapy recipient ) determine Investigator Be take Tumor Necrosis Factor ( TNF ) blocker Be participate another research study Have sensitivity porcine material Have life expectancy le 1 year Have study wound third degree burn wound Have study wound infect Have study wound pressure ulcer/wound Have study wound sinus tract ( ) lead open area ( ) Have wind treat expect treat either HBOT topical wound oxygen therapy Have study wound treat cellular and/or tissuebased product within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>